Literature DB >> 20363453

Pay for performance in neonatal-perinatal medicine--will the quality of health care improve in the neonatal intensive care unit? A business model for improving outcomes in the neonatal intensive care unit.

Alan R Spitzer1.   

Abstract

Because neonatal medicine is such an expensive contributor to health care in the United States--with a small population of infants accounting for very high health care costs--there has been a fair amount of attention given to this group of patients. An idea that has received increasing attention in this discussion is pay for performance. This article discusses the concept of pay for performance, examines what potential benefits and risks exist in this model, and investigates how it might achieve the desired goals if implemented in a thoughtful way. Copyright 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20363453     DOI: 10.1016/j.clp.2010.01.010

Source DB:  PubMed          Journal:  Clin Perinatol        ISSN: 0095-5108            Impact factor:   3.430


  4 in total

Review 1.  Lessons from healthcare providers' attitudes toward pay-for-performance: what should purchasers consider in designing and implementing a successful program?

Authors:  Jin Yong Lee; Sang-Il Lee; Min-Woo Jo
Journal:  J Prev Med Public Health       Date:  2012-05-31

2.  2,4,5-Triphenyl-1-(prop-2-en-1-yl)-1H-imidazole.

Authors:  Mehmet Akkurt; Shaaban K Mohamed; Adel A E Marzouk; V M Abbasov; Francisco Santoyo-Gonzalez
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2013-05-31

3.  Seven years later: state neonatal risk-appropriate care policy consistency with the 2012 American Academy of Pediatrics Policy.

Authors:  Charlan D Kroelinger; Marion E Rice; Ekwutosi M Okoroh; Carla L DeSisto; Wanda D Barfield
Journal:  J Perinatol       Date:  2021-07-12       Impact factor: 3.225

4.  Quantification of EUGR as a Measure of the Quality of Nutritional Care of Premature Infants.

Authors:  Zhenlang Lin; Robert S Green; Shangqin Chen; Hui Wu; Tiantian Liu; Jingyang Li; Jia Wei; Jing Lin
Journal:  PLoS One       Date:  2015-07-20       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.